DVA · DaVita Inc
United States · RS rating 58 · As of 2026-10-14
| Price | 180.70 USD |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 58 / 36 / 17 / 88 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 40 / 51 / 36 |
| Industry group (rank) | Medical-Outpnt/Hm Care (25) |
| EPS growth Q/Q | +61.3% |
| Sales growth Q/Q | +5.8% |
| Distance from 52-week high | +25.0% |
| Market cap (USD) | $10.2B |